BackBalance Labs Overview

Balance Labs EBIT

Balance Labs's EBIT is $-17M, below the sector sector average of $2.6T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$500.56K
↓ 458.52% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

-$16.58M
↓ 7037.89% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Balance Labs (BLNC) FAQ

The latest EBIT for BLNC is $-17M as of June 2026. That compares with $-230K in the prior-year period — down 7037.9% year over year. That is below the sector sector average of $2.6T. Investors often review this figure alongside Balance Labs's historical trend and sector peers before judging valuation or financial health.

Over the past year, BLNC's EBIT moved from $-230K to $-17M — a 7037.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Balance Labs's operating scale or balance-sheet position.

Against its sector companies, BLNC currently prints $-17M for EBIT, while the sector average sits near $2.6T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Balance Labs's growth, margins, and balance sheet.

A EBIT figure of $-17M for BLNC is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.6T. Explore the charts below for those layers of context.

After noting BLNC's EBIT ($-17M), review year-over-year change from $-230K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.